| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024066 |
| Receipt No. | R000027712 |
| Official scientific title of the study | An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients |
| Date of disclosure of the study information | 2016/09/15 |
| Last modified on | 2017/06/21 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients | |
| Title of the study (Brief title) | An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients | |
| Region |
|
|
| Condition | ||
| Condition | advanced cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate whether fucoidan as a supportive care agent could alleviate inflammatory conditions and maintain quality of life (QOL) in advanced cancer patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Changes in inflammatory biomarkers including high-sensitivity CRP, and pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alfa) during the study period of 4w. |
| Key secondary outcomes | Changes in QOL scores using EORTC QLQ-C30 during the study period of 4w. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | receive 400 ml/day of fucoidan (Trade name: Power Fucoidan, Daiichi Sangyo, Co. Ltd. Osaka, Japan) for at least 4 weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) clinically diagnosed with inoperable metastatic cancer,
(2) aged over 20 years, (3) ambulatory as an outpatient with normal food intake for at least 4 weeks during the study, |
|||
| Key exclusion criteria | with serious dysfunction of vital organs. | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Mitsuhiko Kawaguchi |
| Organization | Kawaguchi Medical Clinic |
| Division name | Division of Internal Medicine |
| Address | 2-2-16, Daiku, Kita-ku, Okayama-shi, Okayama Japan 700-913 Japan |
| TEL | 086-222-0820 |
| nqp02936@nifty.com | |
| Public contact | |
| Name of contact person | Hidenori Takahashi |
| Organization | University of the Ryukyus Hospital |
| Division name | Division of Community-based Medicine and Primary Care |
| Address | 207 Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 903-0215, Japan |
| TEL | 098-895-1331 |
| Homepage URL | |
| bzr06263@med.u-ryukyu.ac.jp | |
| Sponsor | |
| Institute | Kawaguchi Medical Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Daiichi Sangyo, Co. Ltd. Osaka, Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 川口メディカルクリニック(岡山県)、喜多村クリニック(福岡県)、セレンクリニック福岡(福岡県)、堂島リーガクリニック(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | http://journals.sagepub.com/doi/full/10.1177/1534735417692097 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027712 |